None listed
Conditions
Interventions
Medical Device : The intervention in this study is ultrasound-guided transversus abdominis plane block using a mixture of Welpass, a thermo-responsive gel, and 0.75% ropivacaine (TRG-TAPB). During min
Sponsors
Seoul National University Bundang Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ? Adults aged 19 years or older and younger than 85 years ? Patients scheduled to undergo one of the following minimally invasive upper gastrointestinal surgeries: i Laparoscopic gastrectomy ii Robot-assisted gastrectomy ? Patients who voluntarily agree to participate in the study
Exclusion criteria
Exclusion criteria: ? Patients for whom ropivacaine administration is contraindicated i Patients with hypersensitivity to amide-type local anesthetics, including ropivacaine ii Patients with massive bleeding or shock iii Patients with sepsis ? Patients with a body mass index (BMI) of less than 18 kg/m² ? Patients with severe hepatic or renal disease ? Patients who complain of chronic pain or hyperalgesia ? Patients who have received opioids for more than 1 month before surgery ? Patients who are judged by the investigator to be inappropriate for participation in the study for any other reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Thermo-responsive gel-related complications;Ropivacaine-related complications;Procedure-related complications | — |
Secondary
| Measure | Time frame |
|---|---|
| Plasma ropivacaine concentration;Postoperative NRS pain score;Cumulative opioid consumption;QoR-15K score;Postoperative antiemetic requirement;Patient satisfaction with postoperative pain control (7-point Likert scale) | — |
Countries
Korea, Republic of
Contacts
Public ContactDongjae Jeon
Seoul National University Bundang Hospital
Outcome results
None listed